Return On Equity	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Y / Y Equity Change	-	-88.33 %	-55.77 %	-	-
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-	-	-	-	-

VRPX all Ratios >> Back to VRPX Management Effectiveness >> See Quarterly VRPX Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Dec 31 2024) ROE improved to 1320.61 % compare to previous year, due to net income growth.

Financial Statements
Virpax Pharmaceuticals Inc 's Equity	$ -1 Millions	Annual VRPX's Balance sheet
Virpax Pharmaceuticals Inc 's Annual Income	$ -12 Millions	Annual VRPX's Income Statement
Where are VRPX's Income coming from?		Visit VRPX's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.